Senior Neuromuscular Clinical Sales Leader

Sarepta Therapeutics; Denver (CO); Hybrid; USD 173,000 - 217,000; Full time

Benefits offered by this job

Physical and Emotional Wellness

Financial Wellness

Support for Caregivers

Job summary

Sarepta Therapeutics seeks a Sr. Neuromuscular Clinical Sales Specialist to promote our Duchenne therapies to medical providers across a defined US geography. The role drives enrollment form attainment and builds referral networks with physicians and hospitals.

The position requires travel up to 70%, a Bachelor’s degree, and a track record of exceeding sales goals in biotech or orphan diseases. Hybrid on-site work within the United States is expected, with competitive compensation provided.

Qualifications

• Bachelor's degree required; 7+ years in biotech field sales preferred.
• Neuromuscular, Pediatric Neurology or other specialty experience preferred.
• Excellent consultative selling skills with proven performance history.

Responsibilities

• Promotes Sarepta therapies to medical providers in assigned US territory.
• Drive enrollment form attainment for Amondys 45, Exondys 51, Vyondys 53 and Elevidys.
• Build and maintain relationships with key HCPs across Sites of Care.
• Lead weekly in-person meetings with referring and treating physicians.
• Develop strategic account plans with defined sales objectives and coverage.
• Stay current on DMD environment and regulatory guidelines.

Skills

Consultative selling

Communication skills

MS Office / Veeva / Salesforce

Travel readiness

Driver's license

Education

Bachelor's degree

7+ years field experience

Tools

Veeva

Salesforce

MS Office

Job description

Sarepta Therapeutics seeks a Sr. Neuromuscular Clinical Sales Specialist to promote our Duchenne therapies to medical providers across a defined US geography. The role drives enrollment form attainment and builds referral networks with physicians and hospitals.

The position requires travel up to 70%, a Bachelor’s degree, and a track record of exceeding sales goals in biotech or orphan diseases. Hybrid on-site work within the United States is expected, with competitive compensation provided.